Categories: aggregated

DEA Hit with Another Marijuana Lawsuit Yet Again

It’s no secret that the only cannabis available for official use on research is provided by the University of Mississippi and NIDA, which is notoriously low in quality. The lawsuit also states that this marijuana is unfit for research because of “poor quality, unstable supply, and limited variability that in no way emulates the types of cannabis currently available through either state-regulated markets or informal markets where regulated supply is unavailable.” What makes it worse is that this cannabis is only allowed for research and not to be sold commercially, which means that it can’t be used for Phase 3 studies of the FDA, required under the Good Manufacturing Processes.

AddThis Website Tools
Jason

Share
Published by
Jason

Recent Posts

How Much Does an Ounce of Weed Cost Right Now? – What Should You Be Paying for an Ounce of Cannabis?

How much should an ounce of weed cost? As the U.S. cannabis market surges past…

12 hours ago

Leafly’s top 10 high-potency hemp products of 2025

Find the best high-potency hemp products of 2025. Leafly reviewed popular hemp products & chose…

2 days ago

THCA is on the rise, and The Hemp Doctor knows why.

A breakdown of the situation regarding hemp, cannabis, and THCA—courtesy of The Hemp Doctor. The…

2 days ago

Trump is Causing Americans to Smoke More Weed (But It’s Not Just Him)

Well, folks, it looks like Donald Trump might be the best thing to happen to…

3 days ago

How Big Alcohol is Trying to Takeover the Legal Marijuana Industry (And They’re Not Even Subtle About It)

In a policy memo that reeks of entitlement, the American Beverage Licensees (ABL) trade association…

4 days ago

Someone is Flooding America with Cannabis Seeds, and Now We Know Why!

A surprising shift has caught the eye of analysts and regulators: a European company has…

1 week ago